Skip to main content
In-Vitro Research Only
Sign in

SS-31 (Elamipretide): Targeting Cardiolipin to Restore Mitochondrial Bioenergetics

Amino Peptides Research Desk17th Jul 2026

SS-31 (Elamipretide): Targeting Cardiolipin to Restore Mitochondrial Bioenergetics
AT A GLANCE · KEY RESEARCH SUMMARY

What You Need to Know About SS-31

Primary Focus
Mitochondrial inner-membrane research
Molecular Profile
Mitochondria-targeted tetrapeptide
Fridge Storage
2°C–8°C (12–24 Months)
Quality Standard
99%+ HPLC Verified
  • SS-31, also called elamipretide, is a mitochondria-targeted tetrapeptide studied at the inner membrane.
  • Published models follow its interaction with cardiolipin and later changes in mitochondrial output.
  • It is the third piece of the NAD+ and MOTS-c stack when a laboratory wants the membrane as well as the redox pool.
  • A 99%+ HPLC-verified, freeze-dried vial at 2°C–8°C is what makes that three-way comparison repeatable.

How SS-31 Fixes the Leaky Inner Membrane of Tired Mitochondria

SS-31 (Elamipretide) is a four-amino-acid peptide that travels straight to the inner mitochondrial membrane to restore cellular energy production at its source. It binds directly to a specialised fat molecule called cardiolipin, stopping oxidative leaks and helping older or stressed cells generate adenosine triphosphate (ATP) at youthful rates.

Every cell in the body relies on mitochondria to turn nutrients into usable fuel. Inside each mitochondrion, the inner membrane folds into tight ridges called cristae. These ridges hold the electron transport chain—a line of protein complexes that pass electrons along to pump out ATP. Cardiolipin is the structural glue that holds these ridges in their sharp, curved shape so the complexes sit close together.

As tissues age or face metabolic stress, reactive oxygen species attack cardiolipin. When cardiolipin oxidises, the tight folds flatten out. The electron transport complexes drift apart, electrons leak out to create even more free radicals, and ATP output drops. Worse still, oxidised cardiolipin flips an essential protein called cytochrome c from an electron carrier into a lipid-destroying enzyme.

SS-31 vial
IN STOCK UK · 99%+ HPLC PURITY · NEXT-DAY DISPATCH

SS-31

From £41

Supplied as a sealed freeze-dried vial (stable 12–24 months at 2°C–8°C in a standard refrigerator).

Shop SS-31 →

Published studies show that SS-31 slips across the outer cellular barrier and concentrates up to five thousand times inside the inner mitochondrial membrane. Because it carries alternating aromatic and basic amino acids, it hugs cardiolipin through gentle electrostatic forces without altering healthy membranes. Once bound, SS-31 shields cardiolipin from oxidation, keeps cytochrome c doing its normal job of moving electrons, and pulls the protein complexes back into tight supercomplexes. Preclinical models show this physical stabilisation rapidly restores mitochondrial bioenergetics in high-demand tissues such as skeletal muscle, heart muscle, retinal cells, and kidney tubules.

What Published Studies Observe from Hour One to Week Eight

In laboratory models, the response to SS-31 splits clearly into two phases: an immediate biochemical shift followed by slower structural tissue remodelling. Because SS-31 does not rely on building brand-new mitochondria from scratch to start working, the first wave of activity appears remarkably fast.

Within the first one to four hours of exposure in isolated cell cultures and aged rodent tissues, researchers observe a sharp drop in mitochondrial reactive oxygen species. By physically stabilising cardiolipin and stopping electron leakage at Complex I and Complex III, SS-31 improves the ratio of ATP produced per molecule of oxygen consumed. In aged skeletal muscle models, a single measured level of SS-31 improved maximal mitochondrial ATP synthesis and reduced muscle fatigue markers within sixty minutes, bringing cellular energetics closer to those seen in young control groups.

The second phase unfolds over several weeks of steady protocol ratios in preclinical models. Between week two and week four, cells no longer spend all their energy fighting oxidative damage. Instead, they begin repairing the physical architecture of the mitochondria. Electron microscopy from eight-week laboratory studies shows that flattened, swollen mitochondrial cristae gradually regain their tight, folded curves. Alongside this structural recovery, gene expression patterns in stressed heart and kidney tissues shift back toward normal baseline signalling. Fibrotic markers quieten down, and natural cellular cleanup pathways—known as mitophagy—clear out damaged organelle fragments more efficiently. In short, early hours bring cleaner electron flow and steadier ATP output, while multi-week study timelines reveal physical membrane restoration and long-term tissue resilience.

Key Study Insight: Key Study Insight: Unlike classic antioxidants that try to mop up free radicals after they escape, SS-31 binds directly to cardiolipin to stop electron leakage before it starts. Preclinical models show this restores ATP output in aged mitochondria within hours without altering healthy young cells.

Mitochondrial Research Compounds: SS-31 vs Other Bioenergetic Agents

PropertySS-31 (Elamipretide)MOTS-cMitoQ
Molecular ClassSynthetic Szeto-Schiller tetrapeptideMitochondrial-derived 16-amino-acid peptideTriphenylphosphonium-linked ubiquinone
Primary TargetCardiolipin on the inner mitochondrial membraneAMPK pathway and nuclear metabolic genesMitochondrial matrix free radicals
Uptake MechanismPotential-independent diffusion across membranesTranslocation to nucleus during cellular stressDriven by mitochondrial membrane voltage
Core Observation in ModelsRestores cristae structure and optimises ATP synthesisRegulates glucose utilisation and metabolic homeostasisScavenges lipid peroxyl radicals directly
Effect on Depolarised MitochondriaRetains full entry even when membrane voltage dropsSignalling depends on stress-induced activationUptake drops sharply if membrane potential is lost

Pairing SS-31 with Complementary Peptides for Broader Cellular Support

Because SS-31 works specifically as a structural stabiliser for existing inner mitochondrial membranes, researchers frequently pair it with compounds that act on complementary cellular pathways. Rather than overlapping on the exact same target, a well-designed laboratory stack addresses fuel supply, new organelle growth, and broader tissue recovery at the same time.

Reconstitution calculator

Choose a vial mass and a bacteriostatic reconstitution solution volume. The figure is the resulting concentration.

Vial mass
Bacteriostatic reconstitution solution

Concentration: 2.50 mg/mL

Per 0.01mL (10µL): 25.0 mcg

Open the full calculatorBacteriostatic reconstitution solution

A primary partner in bioenergetic research is MOTS-c, a mitochondrial-derived peptide encoded within the 12S rRNA region. While SS-31 repairs the physical efficiency of the electron transport chain inside the mitochondrion, MOTS-c activates the AMPK pathway in the surrounding cell fluid to improve glucose uptake and fatty acid oxidation. Together, MOTS-c brings the raw fuel into the cell while SS-31 ensures the mitochondrial furnace burns that fuel cleanly without leaking free radicals.

Another common pairing involves NAD+ precursors or direct NAD+ study protocols. The electron transport chain stabilised by SS-31 requires a constant supply of NADH to donate electrons at Complex I. Combining membrane stabilisation with healthy NAD+ pools prevents bottlenecks in high-output metabolic assays. Researchers exploring systemic tissue remodelling also look at peptide hormones for broader signalling comparisons, or pair mitochondrial support alongside a GHRP-6 research peptide protocol to observe how restored cellular ATP levels influence growth-factor-driven protein synthesis and structural repair in aged muscle models.

Finally, antioxidant peptides or ubiquinol (CoQ10) assays often run parallel to SS-31. Because cardiolipin anchors CoQ10 near Complex III, keeping cardiolipin intact directly enhances the electron-shuttling efficiency of CoQ10 across the inner membrane.

SS-31 (Elamipretide): Targeting Cardiolipin to Restore Mitochondrial Bioenergetics

Figure: SS-31 (Elamipretide): Targeting Cardiolipin to Restore Mitochondrial Bioenergetics

Why 99%+ HPLC Purity and TFA Removal Matter for Mitochondrial Assays

When studying a peptide that concentrates thousands of times inside the delicate inner membrane of the mitochondrion, vial quality determines whether an experiment succeeds or fails. Low-grade synthesis leaves behind chemical hitchhikers that directly sabotage cellular energy readouts.

The biggest hidden issue in poorly purified peptides is trifluoroacetic acid (TFA). During solid-phase synthesis, manufacturers use TFA to cleave the peptide chain from its resin. If the lab skips secondary ion-exchange steps, residual TFA salts stay bound to the positive charges on SS-31. When introduced to cell cultures, free TFA alters intracellular pH and acts as an uncoupler—meaning it pokes chemical holes in the exact mitochondrial membrane SS-31 is supposed to stabilise. High-grade SS-31 undergoes strict TFA removal, swapping toxic fluoride salts for benign acetate or hydrochloride counter-ions, and is verified to at least 99% purity via High-Performance Liquid Chromatography (HPLC) and mass spectrometry.

Proper storage is equally straightforward but vital for preserving the D-arginine and dimethyltyrosine residues that give SS-31 its shape. Lyophilised (freeze-dried) powder comes sealed in clear borosilicate glass vials and should be kept at -20°C for long-term archiving, or between 2°C and 8°C in a standard laboratory fridge for routine work. Once mixed with a sterile bacteriostatic reconstitution solution, the liquid peptide must stay refrigerated at 2°C to 8°C away from bright light. Gently swirling the vial rather than shaking it prevents shear stress on the peptide bonds, ensuring consistent, repeatable bioenergetic data across every assay.

Frequently Asked Questions

Why is SS-31 (Elamipretide) so widely searched in cellular research?

Researchers investigate SS-31 because it directly binds to cardiolipin inside the inner mitochondrial membrane to optimise cellular energy production. Published studies show this unique mechanism helps stabilise the electron transport chain, reduce oxidative stress, and support cellular recovery in ageing or stressed laboratory models without altering healthy mitochondria.

What is the typical timeline observed in SS-31 laboratory models?

In preclinical models, mitochondrial bioenergetic shifts often appear within hours of introducing the measured level, while broader tissue remodelling is typically evaluated over four to eight weeks. Scientists analyse both immediate adenosine triphosphate output and longer-term markers of cellular regeneration to characterise how the peptide performs over time.

Can SS-31 be combined with other compounds in laboratory protocols?

Yes, researchers frequently pair SS-31 with peptides like MOTS-c or NAD+ precursors in laboratory models to study synergistic effects on cellular metabolism. While SS-31 stabilises the physical structure of the mitochondrial membrane, complementary compounds are analysed for their ability to support broader metabolic signalling pathways during parallel experiments.

How should SS-31 be stored to maintain optimal purity?

Lyophilised SS-31 powder must be stored in a freezer at minus 20 degrees Celsius to preserve its structural purity. Once mixed with a bacteriostatic reconstitution solution for laboratory testing, the liquid should be kept in a dark refrigerator between 2 and 8 degrees Celsius and utilised within a few weeks.

Bibliography

  • Szeto HH. First-in-class cardiolipin-protective compound as a biological agent to restore mitochondrial bioenergetics. Br J Pharmacol. 2014;171(8):2029-2050. View published research
  • Birk AV, Liu S, Soong Y, et al. The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. J Am Soc Nephrol. 2013;24(8):1250-1261. View published research
  • Chavez JD, Tang X, Campbell MD, et al. Mitochondrial protein interaction landscape of SS-31. Proc Natl Acad Sci U S A. 2020;117(26):15363-15373. View published research
  • Campbell MD, Duan J, Samuelson AT, et al. Improving mitochondrial function with SS-31 reverses age-related redox stress and improves exercise tolerance in aged mice. Free Radic Biol Med. 2019;134:268-281. View published research

⚠️ Research Use Only Disclaimer: All peptides and compounds are sold strictly for in-vitro laboratory research purposes only. Not intended for human or veterinary use, not a dietary supplement, and not approved to diagnose, treat, cure, or prevent any disease or condition. For use by qualified researchers in suitably equipped laboratory environments only. Amino Peptides Ltd operates in full compliance with UK MHRA regulations and applicable EU research chemical guidelines.